14.40
+0.44
+(3.15%)
As of 11:14:03 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.92 | -0.86 | -3.14 | 0 |
| Low Estimate | -0.92 | -0.86 | -3.14 | 0 |
| High Estimate | -0.92 | -0.86 | -3.14 | 0 |
| Year Ago EPS | -- | -- | -- | -3.14 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | 7.3M | 8.4M | 35.06M | -- |
| Low Estimate | 7.3M | 8.4M | 35.06M | -- |
| High Estimate | 7.3M | 8.4M | 35.06M | -- |
| Year Ago Sales | -- | -- | 39.1M | -- |
| Sales Growth (year/est) | -- | -- | -10.32% | -- |
Earnings History
| Currency in CHF | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|
| EPS Est. | -0.94 | -0.9 | -0.83 |
| EPS Actual | -- | -- | -- |
| Difference | -- | -- | -- |
| Surprise % | -- | -- | -- |
EPS Trend
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.92 | -0.86 | -3.14 | 0 |
| 7 Days Ago | -0.92 | -0.86 | -3.14 | 0 |
| 30 Days Ago | -0.92 | -0.86 | -3.14 | 0 |
| 60 Days Ago | -0.92 | -0.86 | -1.95 | 0 |
| 90 Days Ago | -0.92 | -0.86 | -1.95 | 0 |
EPS Revisions
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SANN.SW | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Related Tickers
NWRN.SW Newron Pharmaceuticals S.p.A.
6.40
-3.61%
IDIA.SW Idorsia Ltd
1.1200
+1.08%
MOLN.SW Molecular Partners AG
3.2150
-1.08%
CELUW Celularity Inc.
0.0400
+11.11%
RLF.SW Relief Therapeutics Holding SA
2.4950
+1.01%
EVE.SW Evolva Holding SA
1.2550
-2.71%
BION.SW BB Biotech AG Ord
26.60
-0.93%
CUV.AX Clinuvel Pharmaceuticals Limited
10.70
-0.56%
TRDA Entrada Therapeutics, Inc.
7.87
-0.63%
0M4.BE Mersana Therapeutics Inc
0.3015
-4.80%